William Pickering
Stock Analyst at Bernstein
(1.39)
# 3,499
Out of 5,072 analysts
30
Total ratings
47.06%
Success rate
-1.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $9.68 | -7.02% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $176.82 | -11.21% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $55.50 | +58.56% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $8.35 | +73.65% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $71.20 | +1.12% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $761.45 | +2.57% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $18.91 | -31.25% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $434.23 | -28.61% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $44.26 | -45.77% | 2 | Nov 29, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $78.52 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $424.00 | - | 5 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $37 | $23.62 | +56.65% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.35 | +344.44% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $51.25 | -14.15% | 1 | Mar 21, 2023 |
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $9.68
Upside: -7.02%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $176.82
Upside: -11.21%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $55.50
Upside: +58.56%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $8.35
Upside: +73.65%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $71.20
Upside: +1.12%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $761.45
Upside: +2.57%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $18.91
Upside: -31.25%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $434.23
Upside: -28.61%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $44.26
Upside: -45.77%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $78.52
Upside: -
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $424.00
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $23.62
Upside: +56.65%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.35
Upside: +344.44%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $51.25
Upside: -14.15%